Plain-English translation of NCT04755101 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a newer procedure called cardio-neuromodulation, which uses targeted ablation (a heat-based technique) to modify specific nerve pathways in the right side of the heart. The goal is to help people who experience recurrent fainting episodes caused by an overactive vagal nerve response. Early studies suggest this treatment may reduce fainting by over 90%.
Current treatments for nerve-related fainting have limited effectiveness, and many patients continue to have episodes that interfere with their quality of life. This study aims to see if this newer, less invasive nerve-ablation approach offers a safer and more effective option than existing therapies.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will be randomly assigned to either receive the ablation procedure or a sham procedure (a fake procedure for comparison). You'll undergo heart imaging (CT scan) before the procedure, and the actual treatment will be performed under general anesthesia in a hospital setting. All patients will also have heart testing and medication evaluation as part of the study protocol. You will be followed up to monitor whether your fainting episodes decrease and to check for any side effects.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
Belgium